Insufficient scRNA-seq data for expression of QRFPR at single-cell level.
Insufficient scRNA-seq data for expression of QRFPR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 99.09 | 89 / 89 | 83% | 16.34 | 745 / 901 |
thymus | 85% | 41.94 | 556 / 653 | 39% | 1.48 | 233 / 605 |
adrenal gland | 88% | 21.57 | 227 / 258 | 29% | 4.94 | 66 / 230 |
heart | 97% | 66.42 | 831 / 861 | 0% | 0 | 0 / 0 |
esophagus | 41% | 11.76 | 596 / 1445 | 36% | 5.05 | 65 / 183 |
brain | 59% | 23.95 | 1547 / 2642 | 12% | 0.17 | 85 / 705 |
ovary | 61% | 10.90 | 110 / 180 | 1% | 0.06 | 4 / 430 |
intestine | 50% | 9.57 | 485 / 966 | 5% | 0.24 | 24 / 527 |
prostate | 53% | 10.03 | 131 / 245 | 1% | 0.01 | 5 / 502 |
uterus | 24% | 3.65 | 41 / 170 | 17% | 1.11 | 76 / 459 |
adipose | 31% | 8.05 | 379 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 31% | 5.10 | 408 / 1335 | 0% | 0 | 0 / 0 |
breast | 22% | 4.64 | 102 / 459 | 7% | 0.42 | 79 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 29% | 2.51 | 13 / 45 |
lung | 13% | 5.29 | 76 / 578 | 15% | 1.47 | 178 / 1155 |
skin | 16% | 1.89 | 287 / 1809 | 6% | 1.11 | 29 / 472 |
muscle | 20% | 2.75 | 161 / 803 | 0% | 0 | 0 / 0 |
stomach | 12% | 1.40 | 44 / 359 | 2% | 0.04 | 7 / 286 |
bladder | 0% | 0 | 0 / 21 | 8% | 0.44 | 40 / 504 |
pancreas | 4% | 0.35 | 14 / 328 | 2% | 0.04 | 4 / 178 |
liver | 2% | 0.15 | 4 / 226 | 2% | 0.06 | 7 / 406 |
peripheral blood | 0% | 0.03 | 4 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.03 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0042277 | Molecular function | peptide binding |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0004983 | Molecular function | neuropeptide Y receptor activity |
Gene name | QRFPR |
Protein name | G protein-coupled receptor 103, isoform CRA_a (Pyroglutamylated RFamide peptide receptor) Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155) QRFPR protein Pyroglutamylated RFamide peptide receptor |
Synonyms | GPR103 hCG_1778361 |
Description | FUNCTION: Receptor for the orexigenic neuropeptide QRFP. The activity of this receptor is mediated by G proteins that modulate adenylate cyclase activity and intracellular calcium levels. . |
Accessions | ENST00000394427.3 G4XH69 J3KNR3 Q96P65 ENST00000334383.9 F2Z3L3 A1A4W1 ENST00000507331.5 |